SynCore Biotechnology Co Ltd Working Capital to Net Assets Ratio
SynCore Biotechnology Co Ltd working capital to net assets ratio. SynCore Biotechnology Co Ltd (4192) has a Working Capital to Net Assets ratio of 82.7% as of September 2025. Working capital of NT$213.31 Million (current assets of NT$228.19 Million minus current liabilities of NT$14.88 Million) is measured against net assets of NT$257.97 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check SynCore Biotechnology Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of SynCore Biotechnology Co Ltd (2015–2024)
Working capital to net assets ratio of SynCore Biotechnology Co Ltd from 2015 to 2024. This chart shows how SynCore Biotechnology Co Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of September 2025, the ratio stands at 82.7%, reflecting working capital of NT$213.31 Million against net assets of NT$257.97 Million TWD. See SynCore Biotechnology Co Ltd (4192) defensive interval to measure how many days the company can operate on defensive assets alone.
SynCore Biotechnology Co Ltd Working Capital to Net Assets Ratio by Year (2015–2024)
SynCore Biotechnology Co Ltd working capital to net assets ratio by year from 2015 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for SynCore Biotechnology Co Ltd from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SynCore Biotechnology Co Ltd assets under control.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 80.9% | NT$238.34 Million | NT$294.69 Million | NT$260.46 Million | NT$22.12 Million | ▼ -0.1 pp |
| 2023 | 81.0% | NT$289.25 Million | NT$357.14 Million | NT$310.48 Million | NT$21.23 Million | ▲ +16.1 pp |
| 2022 | 64.9% | NT$161.59 Million | NT$249.01 Million | NT$348.23 Million | NT$186.64 Million | ▼ -9.4 pp |
| 2021 | 74.3% | NT$329.19 Million | NT$442.92 Million | NT$710.71 Million | NT$381.52 Million | ▲ +4.1 pp |
| 2020 | 70.3% | NT$393.86 Million | NT$560.58 Million | NT$741.98 Million | NT$348.12 Million | ▲ +4.0 pp |
| 2019 | 66.3% | NT$405.53 Million | NT$612.03 Million | NT$538.89 Million | NT$133.36 Million | ▼ -1.9 pp |
| 2018 | 68.2% | NT$481.90 Million | NT$706.70 Million | NT$545.24 Million | NT$63.34 Million | ▲ +6.2 pp |
| 2017 | 62.0% | NT$446.62 Million | NT$720.61 Million | NT$502.05 Million | NT$55.43 Million | ▼ -10.3 pp |
| 2016 | 72.3% | NT$698.67 Million | NT$966.36 Million | NT$747.88 Million | NT$49.21 Million | ▲ +21.7 pp |
| 2015 | 50.6% | NT$426.61 Million | NT$842.81 Million | NT$471.86 Million | NT$45.24 Million | — |